A detailed history of Aquatic Capital Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Aquatic Capital Management LLC holds 279,400 shares of MRNA stock, worth $12 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
279,400
Previous 77,100 262.39%
Holding current value
$12 Million
Previous $9.16 Million 103.95%
% of portfolio
0.49%
Previous 0.34%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $12.9 Million - $25.3 Million
202,300 Added 262.39%
279,400 $18.7 Million
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $7.8 Million - $12.8 Million
77,100 New
77,100 $9.16 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $1.25 Million - $2.06 Million
10,600 New
10,600 $1.25 Million
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $11,713 - $17,659
-100 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $12,646 - $23,505
100 New
100 $17,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.